Streetbeat News

Stock Prices

CI

Cigna Group's (NYSE:CI) short percent of float has risen 7.77% since its last report, with 3.28 million shares sold short, which is 1.11% of all regular shares available for trading. It would take traders 2.12 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Cigna Group's peer group average for short interest as a percentage of float is 8.17%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

KOSS

Koss Corporation's shares are experiencing a surge in trading volume due to heightened interest from retail investors.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 1:00 pm

OB

Over the past 3 months, 8 analysts have published their opinion on Outbrain (NASDAQ:OB) stock. The average price target is $5.88, implying an upside from the current price of $5.17. This average has decreased by 12.89% from the previous average price target of $6.75.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

COP

ConocoPhillips's (NYSE:COP) short percent of float has fallen 12.2% since its last report, with 8.72 million shares sold short, which is 0.72% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Compared to its peers, ConocoPhillips has less short interest as a percentage of float, with an average of 6.26%.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

USB

Analysts have provided various ratings for U.S. Bancorp (NYSE:USB) within the last quarter, with 2 bullish, 2 somewhat bullish, and 8 indifferent. The average price target is $41.33, implying an upside from the current price of $38.42. This average has increased by 9.08% from the previous average price target of $37.89.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 1:00 pm

HZNP

Horizon Therapeutics' Phase 2 trial for daxdilimab, a candidate for treating Systemic Lupus Erythematosus (SLE), failed to meet its primary endpoint. The study did not show a significant difference between daxdilimab and placebo in terms of patient response and oral glucocorticoid dose reduction. No safety concerns were reported. Horizon's shares are down 0.42% premarket.

Portfolio Pulse from Vandana Singh

July 24, 2023 | 1:00 pm

AMC

AMC Theatres (NYSE:AMC) reported its busiest weekend since 2019, with over 7.8 million moviegoers attending its U.S. and international locations. The company set new post-reopening single-day attendance records and recorded its second highest Food & Beverage revenue day in its 103-year history. The opening weekend of BARBIE and OPPENHEIMER were the primary drivers of AMC's success.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 12:54 pm

ADDYY

Adidas AG has received orders worth $565 million for its unsold Yeezy shoes. The company had stopped selling Yeezy shoes after its partnership with Kanye West ended. The sale of the inventory is expected to save Adidas from a large write-off on its stock. The company had previously predicted a loss in fiscal 2023, the first operating loss in 31 years. Adidas is expected to update its revenue and profit guidance to reflect the initial sale of Yeezy inventory.

Portfolio Pulse from Shivani Kumaresan

July 24, 2023 | 12:53 pm

ALNY

RHHBY

Alnylam Pharmaceuticals has entered a strategic agreement with Roche Holdings to develop and commercialize zilebesiran, a treatment for hypertension currently in Phase 2 of development. Alnylam will receive an upfront cash payment of $310 million and is eligible for additional payments, including development milestone payments over the next few years, as well as regulatory and sales milestones, for a potential deal value of up to $2.8 billion. Alnylam and Roche will co-commercialize zilebesiran in the U.S., with Roche having exclusive rights to commercialize outside the U.S.

Portfolio Pulse from Vandana Singh

July 24, 2023 | 12:51 pm

MCHI

CNBC Mad Money host Jim Cramer and Charles Schwab Chief Investment Strategist Liz Ann Sonders commented on the rebound in commodity prices, indicating a positive economic outlook. The Baltic dry index, an indicator of the Chinese economy's strength, has pulled back significantly, suggesting lower inflation. The iShares MSCI China ETF (NASDAQ:MCHI) edged down 0.53%.

Portfolio Pulse from Shanthi Rexaline

July 24, 2023 | 12:49 pm